7-7969504-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_138426.4(GLCCI1):c.154G>T(p.Ala52Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000141 in 1,003,292 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138426.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GLCCI1 | NM_138426.4 | c.154G>T | p.Ala52Ser | missense_variant | 1/8 | ENST00000223145.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GLCCI1 | ENST00000223145.10 | c.154G>T | p.Ala52Ser | missense_variant | 1/8 | 1 | NM_138426.4 | P1 | |
GLCCI1-DT | ENST00000428660.1 | n.132+268C>A | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000677 AC: 99AN: 146238Hom.: 0 Cov.: 30
GnomAD4 exome AF: 0.0000455 AC: 39AN: 856946Hom.: 0 Cov.: 29 AF XY: 0.0000427 AC XY: 17AN XY: 398494
GnomAD4 genome AF: 0.000697 AC: 102AN: 146346Hom.: 0 Cov.: 30 AF XY: 0.000800 AC XY: 57AN XY: 71288
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 01, 2022 | The c.154G>T (p.A52S) alteration is located in exon 1 (coding exon 1) of the GLCCI1 gene. This alteration results from a G to T substitution at nucleotide position 154, causing the alanine (A) at amino acid position 52 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at